Cargando…
Improving access to pre-exposure prophylaxis for HIV prescribing in a primary care setting
Although emtricitabine–tenofovir was approved for HIV pre-exposure prophylaxis (PrEP) in 2012, use by persons at risk of acquiring HIV has been limited. Because many primary care providers lacked familiarity and comfort prescribing PrEP, at our institution PrEP prescribing was concentrated among the...
Autores principales: | Lumsden, Joshua, Dave, Amish J, Johnson, Camille, Blackmore, Craig |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9109090/ https://www.ncbi.nlm.nih.gov/pubmed/35551096 http://dx.doi.org/10.1136/bmjoq-2021-001749 |
Ejemplares similares
-
Maintaining access to HIV pre-exposure prophylaxis in a pandemic: A service evaluation of telephone-based pre-exposure prophylaxis provision
por: Henderson, Lindsay, et al.
Publicado: (2022) -
Improving patient access to medication information: a quality improvement project on patient-centred prescribing
por: Todd, Anna, et al.
Publicado: (2021) -
Quality improvement in remote prescribing
por: Bader, Mohamed, et al.
Publicado: (2021) -
Monitoring of Physical Health in Patients Prescribed Antipsychotic Medication Within a Medium-Secure Forensic Inpatient Setting: Assessing Compliance With Guidelines and Improving Procedures
por: Baker, Morven, et al.
Publicado: (2023) -
Increasing routine HIV testing in low and medium secure forensic settings
por: Swain, Rachel, et al.
Publicado: (2021)